Serhat Aytug

401 total citations
7 papers, 337 citations indexed

About

Serhat Aytug is a scholar working on Surgery, Transplantation and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Serhat Aytug has authored 7 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 3 papers in Transplantation and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Serhat Aytug's work include Renal Transplantation Outcomes and Treatments (3 papers), Organ Transplantation Techniques and Outcomes (3 papers) and Renal and Vascular Pathologies (2 papers). Serhat Aytug is often cited by papers focused on Renal Transplantation Outcomes and Treatments (3 papers), Organ Transplantation Techniques and Outcomes (3 papers) and Renal and Vascular Pathologies (2 papers). Serhat Aytug collaborates with scholars based in United States. Serhat Aytug's co-authors include Najma Begum, David L. Reich, David Bernstein, Moro O. Salifu, Mary Lee Vance, Edward R. Laws, Samy I. McFarlane, Dale A. Distant, Eli A. Friedman and Kevin C. Abbott and has published in prestigious journals such as Hepatology, Current Diabetes Reports and American Journal of Nephrology.

In The Last Decade

Serhat Aytug

7 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Serhat Aytug United States	6	219	214	92	55	41	7	337
Tomomi Okubo Japan	13	238 1.1×	190 0.9×	80 0.9×	46 0.8×	9 0.2×	39	364
Taeang Arai Japan	13	276 1.3×	201 0.9×	94 1.0×	49 0.9×	7 0.2×	45	413
Hilla Knobler Israel	4	279 1.3×	258 1.2×	72 0.8×	32 0.6×	11 0.3×	6	367
Donald E. Wheeler United States	9	198 0.9×	134 0.6×	49 0.5×	68 1.2×	5 0.1×	11	319
Emilia Prakoso Australia	11	179 0.8×	145 0.7×	48 0.5×	94 1.7×	4 0.1×	18	326
Lance L. Stein United States	12	207 0.9×	155 0.7×	63 0.7×	83 1.5×	3 0.1×	20	355
Said A. Al‐Busafi Oman	12	253 1.2×	181 0.8×	47 0.5×	176 3.2×	8 0.2×	42	435
Maciej Adler Belgium	8	197 0.9×	182 0.9×	25 0.3×	127 2.3×	3 0.1×	16	307
Ryoichi Narita Japan	8	104 0.5×	97 0.5×	23 0.3×	97 1.8×	6 0.1×	30	257
Imad Asaad United States	8	203 0.9×	75 0.4×	71 0.8×	63 1.1×	3 0.1×	29	274

Countries citing papers authored by Serhat Aytug

Since Specialization

Citations

This map shows the geographic impact of Serhat Aytug's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serhat Aytug with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serhat Aytug more than expected).

Fields of papers citing papers by Serhat Aytug

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serhat Aytug. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serhat Aytug. The network helps show where Serhat Aytug may publish in the future.

Co-authorship network of co-authors of Serhat Aytug

This figure shows the co-authorship network connecting the top 25 collaborators of Serhat Aytug. A scholar is included among the top collaborators of Serhat Aytug based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serhat Aytug. Serhat Aytug is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Aytug, Serhat, Edward R. Laws, & Mary Lee Vance. (2011). Assessment of the Utility of the High-Dose Dexamethasone Suppression Test in Confirming the Diagnosis of Cushing Disease. Endocrine Practice. 18(2). 152–157. 14 indexed citations

2.

Karabıçak, İlhan, et al.. (2011). Long‐term kidney transplant outcome in obese patients in a predominantly African American population. Clinical Transplantation. 25(3). E264–70. 15 indexed citations

3.

Salifu, Moro O., Kevin C. Abbott, Serhat Aytug, et al.. (2010). New-Onset Diabetes after Hemodialysis Initiation: Impact on Survival. American Journal of Nephrology. 31(3). 239–246. 19 indexed citations

4.

Salifu, Moro O., et al.. (2008). Posttransplant diabetes and hypertension: Pathophysiologic insights and therapeutic rationale. Current Diabetes Reports. 8(3). 221–227. 2 indexed citations

5.

Salifu, Moro O., et al.. (2005). Challenges in the diagnosis and management of new-onset diabetes after transplantation. Current Diabetes Reports. 5(3). 194–199. 8 indexed citations

6.

Salifu, Moro O., et al.. (2005). Challenges in the diagnosis and management of renal artery stenosis. Current Hypertension Reports. 7(3). 219–227. 8 indexed citations

7.

Aytug, Serhat, et al.. (2003). Impaired Irs–1/Pi3–Kinase Signaling in Patients With Hcv: A Mechanism for Increased Prevalence of Type 2 Diabetes. Hepatology. 38(6). 1384–1392. 271 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact